Select Committee on Public Administration Minutes of Evidence


Examination of Witnesses (Question Numbers 220-239)

MR DAVID MOBBS, MS RUTH JARRATT AND MR STEPHEN LLOYD

8 JULY 2008

  Q220  Mr Prentice: Well, what about fee-charging hospitals? Do you think you get a bad press? You seem a bit defensive to me.

  Mr Mobbs: Well, sometimes I think there is a degree of cynicism. For example, if you have a hedge fund manager who decides to donate a few million pounds to set up a foundation, or there is a plc out there that decides to reserve a few percentage of revenue to do some good, or a big, multi-national corporation decides to embrace the corporate social responsibility agenda, or somebody comes up with some new form of organisation called a `social enterprise', this is all applauded by politicians and the public, but here you have an organisation, such as Nuffield, which is value-driven, it is going the whole hog, there are no half measures here, we have dedicated our assets and our property, we are investing all of our surplus for the public benefit and we are generally greeted with cynicism during this overall process, and I believe that is absurd.

  Q221  Mr Prentice: Okay, that is very clear. In this era of patient choice, if I had something wrong with me, could I say, "I want to go to that Nuffield hospital that David Mobbs keeps banging on about because it's so good and it's just round the corner"? Would I be able to exercise a choice?

  Mr Mobbs: Broadly, you would, depending on the range of services that we are able to provide.

  Q222  Mr Prentice: Do you have any say at all in who you include or exclude?

  Mr Mobbs: Yes, we determine what services we will offer under the patient choice system.

  Q223  Mr Prentice: Looking at the 10% that comes via the NHS and the 90% that are paying, do the 10% that come via the NHS get the same hospital experience? Do they get flowers in their room? Do they get Wi-Fi? Do they have exactly the same kind of hospital experience as the people who pay?

  Mr Mobbs: Absolutely.

  Q224  Mr Prentice: No difference at all?

  Mr Mobbs: No difference at all.

  Mr Walker: There will be an undercover journalist there next week!

  Q225  Mr Prentice: You say you are not for profit, but of course you, Nuffield, will decide how much you are going to charge the NHS and retain any surpluses.

  Mr Mobbs: No, we operate the tariff that the NHS determines, so we only charge the NHS what it says it can afford.

  Q226  Mr Prentice: Do you contract with the private sector at all?

  Mr Mobbs: We contract with insurance companies.

  Q227  Mr Prentice: What I am trying to get at is that you can use this retained surplus for expanding your operation, buying land, buying buildings, paying consultants over the odds and indeed paying yourself, although I am sure you do not decide your own salary, a huge sum of money. It is in the public record, is it not, that in 2004 you were getting £200,000 a year, and perhaps you would tell the Committee what you are getting now.

  Mr Mobbs: Well, I would rather not bring that up in committee. It is in our Annual Report, if you would like to refer to that, or I am more than happy to provide it in writing, Chairman, unless of course the Committee insist that I bring this up.

  Q228  Mr Prentice: No, I am not insisting, but I am just wondering why you are so coy, that is all. The general point I am making is that you can, by contracting with other health organisations, make a surplus and it is up to the trustees how they spend that surplus by paying your medical people over the odds, by attracting nurses, by paying them more presumably than they would get in the NHS and by paying people like you stratospherically high salaries.

  Mr Mobbs: Well, I will not respond to the last point, but I will respond to the other point. You are absolutely right, we do make a profit, by and large, each year. It is only a temporary profit because it is immediately reapplied for the purposes of the charity for the public benefit.

  The Committee suspended from 4.34pm to 4.45pm for a division in the House.

  Q229 Chairman: I do not know if you remember where you were at, Mr Mobbs.

  Mr Mobbs: I am happy for Mr Prentice to remind me, if you wish, but I believe it was a question of what we spend our surplus on.

  Q230  Mr Prentice: Well, we can take that as my question, yes. Let me focus it a bit more narrowly. It is possible for Nuffield, or is it not the case, that you can pay your clinical staff, your nurses, doctors, consultants and so on, more than they would get from working in NHS hospitals?

  Mr Mobbs: Leaving the doctors to one side for the moment, when it comes to all the other staff, we broadly pay at the market rate.

  Q231  Mr Prentice: Broadly, so there is no question of you poaching staff, giving them better terms and conditions, inducing them to leave NHS hospitals to work for you in Nuffield? Why are you smiling? That was a very straightforward question.

  Mr Mobbs: Well, it is the term "poaching staff". I think staff have a choice to think about where they want to work and I think, if there is competition for employment, with such a large employer as the NHS, all this can do is help the NHS improve its standards on how it treats its staff, but no, we do not offer packages which are generally above the market in comparison to the NHS. In fact, we probably suffer by comparison because, for example, a couple of years ago we had to wind up our final salary pension scheme because it became unpredictable and unaffordable, whereas the state sector continued to provide this under a state subsidy, so, in comparison, no, I do not believe we offer exorbitant packages for our broad range of staff. Doctors are actually independently employed and we are in a marketplace for doctors out there, just as the NHS is.

  Q232  Mr Prentice: How do your terms and conditions compare then with the independent sector?

  Mr Mobbs: Broadly the same.

  Q233  Mr Prentice: So the patient experience is the same, whether they are from the NHS or they are the 90% who pay fees, and there is nothing that distinguishes the experience patients get from your hospitals from the private sector or the NHS?

  Mr Mobbs: Well, I did not actually say that. I believe that the experience that patients get with Nuffield is better than they will get anywhere else. Our patient satisfaction rates are above 96%. Last year, we only recorded one case of MRSA bacteraemia. I think those sorts of standards are very hard to maintain and that is the sort of thing that we spend our surplus on for the public benefit.

  Q234  Mr Prentice: But why should that be the case? We are all interested that there has been only one case of MRSA in a Nuffield hospital, and you will remind me in a minute—

  Mr Mobbs: In 2007.

  Q235  Mr Prentice:— how many Nuffield hospitals there are, but do you spend a lot of money on cleaning?

  Mr Mobbs: Well, we believe we spend the right amount on cleaning and we believe we spend the right amount on ensuring our staff have the right skills when it comes to infection control. We have a whole network of infection control link nurses across our hospitals business, something that the NHS are only just recommending, so we do have very high standards and we do pioneer in those areas. I can give you a copy of our Integrated Clinical Governance Report, which is the first report ever published in the independent sector that brings together all of the quality statistics there. We have extremely high standards, as an organisation.

  Q236  Mr Prentice: That is good. I ask you all these questions because the boundaries between health organisations, if I can put it that way, NHS bodies and independent sector people like Nuffield, are becoming increasingly porous, so these questions are relevant. Now, in the letter that you sent to the Charity Commission in June on their consultation on the draft Public Benefit Guidance, there was one thing you said there which smacked me between the eyes. You said, "We", that is Nuffield, "are very clear that attempting to report a balance sheet of public benefit against tax breaks received would be an onerous and arbitrary exercise, and one that should be rejected". Why should that be? If members of the public think that Nuffield is getting all these tax breaks, that they can generate sufficient surpluses to pay their top people huge sums of money. Is it really asking too much for there to be a list of the public benefit received and the benefits that you, as an organisation, receive from the State?

  Mr Mobbs: I think there are two issues there. Firstly, we do think it is onerous, but it is probably going to be more onerous for non-fee-charging charities, and our view is that, if this approach is going to be taken, all charities receive tax breaks, not just fee-charging charities, that all charities receive a relief in terms of business rates, get zero-rating on some of their VAT input costs, get relief in terms of stamp duty and that some charities get gift aid. If this approach is going to be taken, it should be uniform across the whole of the charity sector because this is not an issue about access, this is an issue about benefit, and again I think the debate confuses benefit with access. What we are saying is that actually, for a fee-charging charity, it might be much easier for us to demonstrate the balance sheet approach, but, for non-fee-charging charities, it is going to be much more onerous because they are going to be in a situation where they are measuring intangible benefits, whereas our benefits are a bit more obvious and a bit more measurable than in that case, so, for the charity sector overall, I think it reduces the whole thing, the whole debate of public benefit into a commodity and a balance sheet, and I think that is the wrong direction for the charity sector. That is why we made that statement.

  Q237  Chairman: Do you want to comment, Ruth?

  Ms Jarratt: Yes, I would like to support this point. I finally got round to making my submission to the Charity Commission only last Friday and I prepared for this, so I apologise if you have not had a chance to see that, but I did make a similar point, that, whilst we probably could do a monetised version that would stack up, I think there are many unquantifiables, so how do you quantify in pound notes the value of creating a new opera? How do you value the preservation of a ballet which, if it is not performed, literally dies? Once there is nobody alive who does that ballet, nobody can recreate it. How do you monetise the value of a young musician out spending time alongside one of the world's greatest conductors, which we arrange regularly? How do you monetise those things? You cannot, so I do think that, whereas one of the questions in the guidance is, "Should this be tightened up? Should it be made more of a balance sheet?", which I think was the term you used, I think that would be unhelpful because, whilst using the idea may not be such a bad idea, you would lose so much, certainly in the arts, in my position, you would lose sight so much of what the public benefit actually is that we are offering.

  Q238  Mr Prentice: No one wants to be kind of mechanistic about these things and it is unfortunate that we have not had an opportunity to read your submission, but what are you actually doing to demystify opera? I know you told us earlier about what you are doing to encourage people to go along, the screens and so on, but, for a lot of people, they just choke at the idea of going along to see an opera.

  Ms Jarratt: The core of it is our educational work which is aimed both at the younger age and at all ages. We talked about barriers and we talked about the money barrier a lot and there is a geographical barrier I mentioned, but there is also a kind of "It's not the sort of thing people like me do" kind of a barrier, if you see what I am saying, a conceptual barrier, you could say, so we do a lot of stuff and, increasingly, not least using online techniques. We used to do sort of talks and all that sort of stuff and now we can do that so much more easily online or whatever. Our core education work right throughout the country, starting at a young age, is possibly the biggest tool, and I think you would find that most arts organisations would be saying that. If kids are introduced at a young age, if the idea of going into a theatre, whoever's, becomes something that happens, it is not too odd, if even opening your own mouth and making a noise or dancing around is something that you get to do that even your mates get to see you doing, it becomes something which is no longer taboo and there are these kind of weird social taboos, if you like. Our total educational programme, whether it is aimed at adults, whether it is aimed at people who are coming to the show tomorrow night or whether it is broadly throughout schools, community groups and young people, is all aimed at the demystification, and we see ourselves having a huge responsibility for, if you like, creating the audience of the future. There is no performing art without an audience, so it is part of our raison d'être.

  Q239 Mr Prentice: Is it ridiculous to think of opera as high-brow? Is that a kind of lexicon we should be using these days?

  Ms Jarratt: I do not think I am here to dictate the terms that people use. If we are talking about some works of art that can stir the soul in a way that maybe very few other things can, if you listen to Capital FM on a Saturday morning when people talk about "the piece of music that reminds me of what matters in life", how often it is an opera aria, if you are talking about those things and you want to use those terms, that is fine, but I think `deep', `profound', those, to me, are more meaningful terms.



 
previous page contents next page

House of Commons home page Parliament home page House of Lords home page search page enquiries index

© Parliamentary copyright 2008
Prepared 8 December 2008